FiEE (FIEE) has had the highest return since January 1, 2025 by a micro-cap US stock, returning 1,184.4%.
| ASSET | % RETURN |
|---|---|
FiEE (FIEE) | 1,184.4% |
Oncology Institute (TOI) | 1,135.29% |
Abits (ABTS) | 805.96% |
Lizhi (SOGP) | 582.23% |
Galecto (GLTO) | 569.46% |
Beneficient Class A Common Stock (BENF) | 544.34% |
XBP Europe (XBP) | 435.51% |
Global Interactive Technologies (GITS) | 397.93% |
9F (JFU) | 391.33% |
Dominari (DOMH) | 390.47% |
Resolute Holdings Management (RHLD) | 367.86% |
Roman DBDR Acquisition Corp II Warrants (DRDBW) | 366.67% |
Precipio (PRPO) | 355.66% |
ImmunoPrecise Antibodies (HYFT) | 331.71% |
Phoenix Asia Holdings Limited Ordinary Shares (PHOE) | 327.5% |
Vista Gold (VGZ) | 319.93% |
JFB Construction Holdings Class A Common Stock (JFB) | 314.68% |
Sol Gel Technologies (SLGL) | 310.63% |
Empro Group Inc Ordinary shares (EMPG) | 307.51% |
Rapid Micro Biosystems (RPID) | 300% |
Blackboxstocks (BLBX) | 283.89% |
Above Food Ingredients Inc Common Stock (ABVE) | 276.36% |
Gold Resource (GORO) | 259.27% |
ABVC BioPharma (ABVC) | 257.63% |
CervoMed (CRVO) | 252.08% |
Micro-cap stocks are treated as having a market cap of <= $300M.
